Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swedish expert calls for xenotranplantation reassessment:

This article was originally published in Clinica

Executive Summary

To successfully take xenotransplantation forward, researchers to concentrate on modifying pig genes rather than concentrating on developing a means to suppress the patient's immune system in order to avoid rejection, says a leading Swedish professor for transplantation surgery. Professor Carl-Gustav Groth of the Karolinska Institute told Lakartidningen that attempts to suppress the human immune system often had side-effects. He also said that pig cells should be considered alongside human cells in the field of cell transplantation, to treat diseases such as diabetes and Parkinson's.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064797

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel